Company overview
BlueNalu develops cell-cultivated seafood products, such as bluefin tuna toro and yellowtail fillets, produced directly from fish cells using cellular aquaculture and extrusion bioprinting technologies. These offerings provide sustainable, high-quality alternatives to conventional seafood, free from mercury, bones, and skin, aimed at supporting ocean conservation and food security. The San Diego-based company collaborates with industry partners to commercialize healthy, safe products for premium markets.
BlueNalu is listed in the NovaPharmaNews Supplier Hub in the life-science supply chain serving United States & Americas. Core focus areas include cell-cultivated seafood, cellular aquaculture, bluefin tuna, yellowtail fillet, sustainable seafood.
Structured facts
- Website
- https://www.bluenalu.com
- Markets served
- United States & Americas
- Keywords
- cell-cultivated seafood, cellular aquaculture, bluefin tuna, yellowtail fillet, sustainable seafood
Products & technologies
Markets served
Company timeline
- — Profile published on NovaPharmaNews
Frequently asked questions
- What cell-cultivated seafood products does BlueNalu offer?
- BlueNalu produces whole-muscle fillets like yellowtail amberjack, bluefin tuna toro, mahi-mahi, and red snapper directly from fish cells, mimicking conventional seafood structure and cooking performance.
- What technology does BlueNalu use for production?
- BlueNalu employs cellular aquaculture with extrusion bioprinting, where fish cells are part of the extruded mixture, enabling scalable production of boneless, skinless seafood portions.
- Is BlueNalu's seafood regulatory compliant and safe?
- BlueNalu focuses on producing healthy, safe, trusted cell-cultured seafood under hygienic conditions, with longer shelf life than wild fish; products align with sustainability goals like UN Global Compact standards.
Related editorial coverage
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
- AACR 2026: AI Pathology & Oncolytic Virus Spark Interest
Explore lab tools and QA/QC resources for R&D teams.
